Loading…
Loading…
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 6/30/26 7/15/26 Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Emerging Markets Debt Fund, Inc. MSD $0.15 Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. EDD $0.24 The amount of net investment income to be paid by the Funds is determined in accordance with federal income tax regulations. It.
[url="]Keysight Technologies, Inc.[/url] (NYSE: KEYS) today announced it has achieved a Hybrid eCall certification to the EN 18052:2025 standard from DEKRA. Th
Morgan Stanley Emerging Markets Debt Fund has rallied since 2022, driven by rising rates, macro improvements, and a weaker US dollar. MSD offers high-yield and diversified exposure to sovereign, corporate, and quasi-sovereign debt across less-tracked emerging markets. The fund maintains a stable distribution history, but recent trends show declining yields and rising risks in emerging markets.
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 3/31/2026 4/15/2026 Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Emerging Markets Debt Fund, Inc. MSD $0.14 Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. EDD $0.14 For more information call: 1-800-231-2608. The amount of net investment income to be paid by the Funds is determined in acc.
COPENHAGEN, Denmark, December 19, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has been informed that MSD (tradename of Merck & Co., Inc., Rahway, NJ, USA) will not exercise its option for Evaxion's Gonorrhea vaccine candidate EVX-B2. Consequently, Evaxion retains global rights to EVX-B2 and will look for another potential licensing partner.
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 12/19/25 1/15/26 Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Short-Term Capital Gains Per Share Long-Term Capital Gains Per Share Morgan Stanley Emerging Markets Debt Fund, Inc. MSD $0.15* (Quarterly) -- -- Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. EDD $0.13* (Quarterly) -- --.
Citi Trends delivered its fifth consecutive quarter of positive comps, underscoring sustained operational momentum and effective merchandising. CTRN projects 2027 sales of $900 million and EBITDA of $45 million, primarily via margin expansion rather than aggressive revenue growth. Despite execution, CTRN trades at 18x FY27 earnings, pricing in optimistic forward assumptions and leaving limited upside.
This month's top 10 closed-end funds offer an average yield of 9.25% and strong long-term performance across diverse asset classes. For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for MSD and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.